G-X Uranium ETF (URA) 10.52 $URA Oil And Uranium Prices

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
G-X Uranium ETF (URA) 10.52 $URA

Oil And Uranium Prices Complementing World Military Trend Growth
Michael Ambrozewicz - at Seeking Alpha - Sun Mar 08, 3:01AM CDT

CCJ: 14.79 (+0.39), URA: 10.52 (+0.14)

Weekly ETF Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Feb 20, 3:16PM CST

VXX: 25.73 (-0.40), PSLV: 6.55 (+0.23), UNG: 14.10 (-0.16), URA: 10.52 (+0.14), OIL: 9.79 (+0.22), SIVR: 16.44 (+0.56), GAZ: 1.40 (+0.05), SLV: 16.00 (+0.56), XLV: 74.90 (+0.33), EWJ: 12.81 (+0.20)

Uranium Participation Corp. At Attractive Entry Price
Tarryn Valle, CFA - at Seeking Alpha - Fri Feb 20, 12:13PM CST

CCJ: 14.79 (+0.39), URA: 10.52 (+0.14), DNN: 0.81 (+0.02)

Uranium: Every Dog Has Its Day
Andrew Hecht - at Seeking Alpha - Tue Feb 17, 2:12PM CST

CCJ: 14.79 (+0.39), URA: 10.52 (+0.14)

The Uranium Bull Is Still Alive, But Paralyzed By The Oil Price Collapse
Peter Arendas - at Seeking Alpha - Tue Jan 20, 2:49AM CST

URA: 10.52 (+0.14)

Energy Fuels and Uranerz to Create the Largest Integrated Uranium Producer Focused on the United States
Marketwired - Mon Jan 05, 6:01AM CST
Energy Fuels Inc. (NYSE MKT: UUUU)(TSX: EFR) ("Energy Fuels" and Uranerz Energy Corporation (NYSE MKT: URZ)(TSX: URZ) ("Uranerz" are pleased to announce the execution of a definitive agreement (the "DA" pursuant to which Energy Fuels will acquire all of the issued and outstanding shares of common stock of Uranerz (the "Transaction". Under the terms of the DA, shareholders of Uranerz will receive 0.255 common shares of Energy Fuels for each share of Uranerz common stock held.
EFR.TO: 6.00 (-0.10), UUUU: 4.75 (+0.02), URA: 10.52 (+0.14), URZ.TO: 1.43 (-0.04), URZ: 1.11 (-0.05)

Uranium: Can You See The Light?
Vulcan Investments - Seeking Alpha - Mon Dec 15, 8:08AM CST
Originally published on July 7, 2014 The Case for Uranium The last four years have taken quite a toll on uranium prices. The current price of uranium is at $28 per pound, a far cry from its 2007 highs. At that time, the price of uranium peaked...
URA: 10.52 (+0.14)

Uranium Is Making A Comeback
Alpha World - at Seeking Alpha - Tue Dec 09, 9:02AM CST

CCJ: 14.79 (+0.39), URA: 10.52 (+0.14)

Spot U3O8 And Uranium Miners Rebound And Retrace As Japan Readies Nuclear Reactor Restarts
InvestorsGuru - at Seeking Alpha - Thu Dec 04, 12:51AM CST
The Sleeper Has Awakened I mostly value investments according to traditional fundamentals, but I also use technical indicators to refine my entry and exit points. My previous articles asked, "is spot U3O8's bottom now in and are uranium...
UUUU: 4.75 (+0.02), UEC: 1.47 (+0.01), CCJ: 14.79 (+0.39), URRE: 1.42 (+0.06), DNN: 0.81 (+0.02), URA: 10.52 (+0.14), URG: 0.95 (-0.02), URZ: 1.11 (-0.05)

Will Uranium ETF Continue To Glow Green Amid Energy Market Rout?
Zacks Funds - Seeking Alpha - Tue Dec 02, 3:01PM CST
Though the broad energy sector has been hit badly in recent months, uranium has shown a nice comeback following the meltdown from the Fukushima disaster in March 2011. In fact, it strongly bounced off as much as 57% from its nine-year low hit in May...
URA: 10.52 (+0.14)

Will Uranium ETF Continue to Glow Green Amid Energy Market Rout? - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Tue Dec 02, 12:00PM CST
Investors are concerned about the sustainable rally in uranium ETF amid the energy market rout and uranium surplus.
URA: 10.52 (+0.14)

Ur-Energy: A Uranium Giant In The Making, Part 3 - Higher Uranium Prices Are Here And That's What We've Been Waiting For
Lazarus Investment Partners - Seeking Alpha - Mon Dec 01, 6:30AM CST
Author's Note: This article discusses a microcap stock. Please be advised of the risks associated with microcap stocks. The text of the interview is an edited transcription of a conversation between Lazarus Investment Partners LLLP and Ur-Energy...
UUUU: 4.75 (+0.02), CCJ: 14.79 (+0.39), URRE: 1.42 (+0.06), URA: 10.52 (+0.14), URG: 0.95 (-0.02)

Historic Turnaround In Uranium Prices And Equities In The Making
Rockstone - at Seeking Alpha - Fri Nov 28, 1:20PM CST
While precious metal prices are under attack once again threatening to drop even further, uranium prices have been accelerating lately and an increasing number of investors are running into uranium equities as a historic turnaround is in the making,...
CCJ: 14.79 (+0.39), URA: 10.52 (+0.14), DNN: 0.81 (+0.02)

Nuclear Energy Returning To Japan Forces Uranium To Step Up
Jeff Opdyke - Seeking Alpha - Fri Nov 28, 9:06AM CST
A funny thing happened on the way to a nuclear-free world - Japan realized what a bad idea that was. You will probably recall that in the wake of the earthquake/tsunami/Fukushima nuclear disaster, Japan shuttered its 50 nuclear power plants, which...
NUCL: 36.15 (+0.27), URA: 10.52 (+0.14), NLR: 49.82 (+0.43)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 87

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 399

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 448

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 72

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 0

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
Ascletis' Preclinical Successes: Future of Obesity Treatment

Updated Category News Views 14

Pharma Giants Eyeing a New Potential Well, it seems the world of pharma is buzzing with Ascletis’ latest developments in the obesity treatment arena. They’ve just showcased some intriguing preclinical data at ObesityWeek® 2026. The standout? A cocktail of advancements that might just put a dent in the obesity epidemic if further studies pan out. ASC30_48: A Daily...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 412

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 89

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Local Voices to Shape Mekong's Story in New Alliance

Updated Category News Views 284

Unpacking the New Storytelling Strategy Right off the bat, let's make it clear—this isn't just another run-of-the-mill environmental project announcement. When the National Geographic Society teams up with ThaiBev to empower Southeast Asian storytellers, they're not just waving around the usual conservation banner. Instead, they're betting on local voices to lead the...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 115

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading

Top 5 Most Recently Viewed Articles

O-I Glass Announces Participation in Citi’s 2025 Conference

Updated Category News Views 208

O-I Glass Participation in the 2025 Basic Materials Conference PERRYSBURG, Ohio — O-I Glass, Inc., known for its commitment to creating exceptional glass products, is set to participate in the upcoming Citi’s 2025 Basic Materials Conference. This significant event will take place on a Wednesday in December, and features notable presentations from O-I's leadership....

Continue Reading
Osmium Partners Proposes Strategic Plan for Articore Growth

Updated Category News Views 104

Osmium Partners Proposes a Four-Step Plan for Articore Osmium Partners has recently made headlines with their proposal for Articore, aiming to elevate shareholder value through a methodical four-step approach. This initiative is driven by Osmium's belief that Articore's current management strategy lacks direction and has resulted in missed opportunities for growth and...

Continue Reading
Amplify Energy Set to Shine at EnerCom Denver Conference 2025

Updated Category News Views 135

Amplify Energy’s Participation in EnerCom Denver Conference Amplify Energy Corp. is gearing up to participate in the renowned annual EnerCom Denver Conference in 2025. This event, known for bringing together leading experts and investors in the energy sector, offers Amplify a prime platform to showcase its strategic initiatives and growth potential. Focus on Investor...

Continue Reading
Safe Life Expands CPR Training and AED Services through Acquisition

Updated Category News Views 197

Safe Life Strengthens National Coverage for Life-Saving Training Safe Life has made a significant move by acquiring HeartCert, a company known for its specialization in automated external defibrillators (AEDs) and CPR training. This acquisition allows Safe Life to broaden its reach into the Midwest, enhancing its commitment to providing life-saving training and equipment...

Continue Reading
Express Scripts Challenges FTC's Drug Pricing Conclusions

Updated Category News Views 106

Express Scripts Files Lawsuit Against the FTC Express Scripts, a major player in the pharmacy benefit manager sector, has recently taken legal action against the U.S. Federal Trade Commission (FTC). This lawsuit stems from a report that criticizes the role of pharmacy benefit managers in the pricing of medications. Express Scripts contends that the report's conclusions...

Continue Reading